Stocktoria
Kymera Therapeutics, Inc. KYMR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-08-21
Kymera Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,155,429 | $124.0M |
| TWO SIGMA INVESTMENTS, LP | 256,501 | $21.4M |
| CITADEL ADVISORS LLC | 155,697 | $13.0M |
| AQR CAPITAL MANAGEMENT LLC | 15,951 | $1.3M |
Source: SEC EDGAR filings · CIK 0001815442 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.